Literature DB >> 15898174

Nosocomial dengue by mucocutaneous transmission.

Lin H Chen, Mary E Wilson.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15898174      PMCID: PMC3320385          DOI: 10.3201/eid1105.040934

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Wagner and colleagues report nosocomial dengue transmitted by needlestick and note that it is the fourth case of nosocomial dengue to their knowledge (1). In the same issue of Emerging Infectious Diseases, Nemes and colleagues report a separate case of nosocomial dengue also transmitted by needlestick (2). Three other cases of nosocomial dengue transmission by needlestick have previously been published (3–5). We have recently published a case of nosocomial dengue infection that was transmitted by mucocutaneous exposure to blood from a febrile traveler who had recently returned from Peru (6). During phlebotomy, a healthcare worker was splashed in the face with the traveler's blood. Both the traveler and the healthcare worker were subsequently found to have dengue fever with dengue virus type 3. This route of infection is biologically plausible because infection through mucosal surfaces (intranasal and oral routes) has been shown possible for arboviruses (7). In our review of the literature, we also found a report of dengue virus transmission by bone marrow transplantation (8). Other cases of transmission of dengue virus without a mosquito vector have occurred in 5 reported instances of infection in newborns as a result of intrapartum or vertical transmission from mother to child (9–12). We agree that nosocomial transmission may become more common in temperate areas as more travelers return home with acute dengue fever. As Wagner and colleagues pointed out, travelers visiting Southeast Asia have the greatest risk of acquiring dengue infections because of the high endemicity of these viruses there. Our report further illustrates the occurrence of dengue infection in the Americas (13) and the risk for dengue to travelers visiting this region. Among 33 returned travelers with dengue infection reported in the United States in 1999 and 2000, 20 had acquired infection in the Caribbean islands (12 cases) or Central or South America (8 cases) (14). Clinicians and laboratorians should be alert to the possibility of acquiring infection with a dengue virus after needlestick or mucocutaneous blood exposure. The magnitude of nosocomial transmission in dengue-endemic areas is unknown and more difficult to assess because healthcare workers may be exposed to dengue virus–infected mosquitoes outside the clinical setting.
  12 in total

1.  The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995.

Authors:  J G Rigau-Pérez; A V Vorndam; G G Clark
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

2.  Transmission of dengue virus without a mosquito vector: nosocomial mucocutaneous transmission and other routes of transmission.

Authors:  Lin H Chen; Mary E Wilson
Journal:  Clin Infect Dis       Date:  2004-08-30       Impact factor: 9.079

3.  [Metropolitan transmission of dengue by accidental inoculation at a hospital].

Authors:  J F Hirsch; C Deschamps; M Lhuillier
Journal:  Ann Med Interne (Paris)       Date:  1990

4.  Vertical transmission of dengue.

Authors:  J K Chye; C T Lim; K B Ng; J M Lim; R George; S K Lam
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

5.  Prenatal transmission of dengue: two new cases.

Authors:  T Boussemart; P Babe; G Sibille; C Neyret; C Berchel
Journal:  J Perinatol       Date:  2001-06       Impact factor: 2.521

6.  Perinatal dengue infection.

Authors:  A Kerdpanich; V Watanaveeradej; R Samakoses; S Chumnanvanakij; T Chulyamitporn; P Sumeksri; C Vuthiwong; C Kounruang; A Nisalak; T Endy
Journal:  Southeast Asian J Trop Med Public Health       Date:  2001-09       Impact factor: 0.267

Review 7.  Transmission of arboviruses without involvement of arthropod vectors.

Authors:  G Kuno
Journal:  Acta Virol       Date:  2001-06       Impact factor: 1.162

8.  Dengue infection complicated by severe hemorrhage and vertical transmission in a parturient woman.

Authors:  P Thaithumyanon; U Thisyakorn; J Deerojnawong; B L Innis
Journal:  Clin Infect Dis       Date:  1994-02       Impact factor: 9.079

9.  Nosocomial acquisition of dengue.

Authors:  Dirk Wagner; Katja de With; Daniela Huzly; Frank Hufert; Manfred Weidmann; Susanne Breisinger; Sabine Eppinger; Winfried Vinzent Kern; Tilman Martin Bauer
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

10.  Nosocomial transmission of dengue.

Authors:  Zsuzsanna Nemes; Gabriella Kiss; Edit P Madarassi; Zoltán Peterfi; Emoke Ferenczi; Tamas Bakonyi; Gabor Ternak
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

View more
  5 in total

Review 1.  Is transfusion-transmitted dengue fever a potential public health threat?

Authors:  Bruno Pozzetto; Meriam Memmi; Olivier Garraud
Journal:  World J Virol       Date:  2015-05-12

2.  Effects of Acute Dengue Infection on Sperm and Virus Clearance in Body Fluids of Men.

Authors:  Joffrey Mons; Dominique Mahé-Poiron; Jean-Michel Mansuy; Hélène Lheureux; Delphine Nigon; Nathalie Moinard; Safouane Hamdi; Christophe Pasquier; Nathalie Dejucq-Rainsford; Louis Bujan
Journal:  Emerg Infect Dis       Date:  2022-06       Impact factor: 16.126

3.  Threat of dengue to blood safety in dengue-endemic countries.

Authors:  Annelies Wilder-Smith; Lin H Chen; Eduardo Massad; Mary E Wilson
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

4.  Update on non-vector transmission of dengue: relevant studies with Zika and other flaviviruses.

Authors:  Lin H Chen; Mary Elizabeth Wilson
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-08-29

5.  An Analysis of a Dengue Outbreak at a Large Hospital and Epidemiological Evidence for Nosocomial Dengue.

Authors:  N D B Ehelepola; W M C M Wijesinghe
Journal:  J Trop Med       Date:  2018-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.